Skip to content

Efficacy and Influencing Factors of Orthokeratology Combined With Low-Dose Atropine in Myopia Control Among Adolescents

Efficacy and Influencing Factors of Orthokeratology Combined With Low-Dose Atropine in Myopia Control Among Adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123578
Enrollment
Unknown
Registered
2026-04-28
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

The observation group:The observation group, receiving OK lens combined with 0.01% atropine eye drops.
The control group:The control group, receiving OK lens alone

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: Adolescents aged 8–12 years with myopia diagnosed according to established ophthalmologic criteria were eligible if they had a spherical equivalent between -1.0 and -6.0 D, astigmatism <1.0 D and less than half of the spherical equivalent, best-corrected visual acuity (LogMAR) = 0.1, intraocular pressure = 21 mmHg, no history of ocular disease, ocular surgery, or trauma, no contraindications to OK lens wear, and written informed consent obtained from the participants and their guardians.

Exclusion criteria

Exclusion criteria: Participants were excluded if they had an allergy or intolerance to atropine or other study-related medications, prior use of contact lenses or atropine for myopia control, inability to comply with scheduled follow-up visits, family history of keratoconus, ocular or systemic conditions affecting visual acuity or myopia progression, use of medications during the study period or other interventions during the study period that could affect refractive outcomes, or participation in other clinical studies during the study period.

Design outcomes

Primary

MeasureTime frame
Myopia progression;

Secondary

MeasureTime frame
Best-corrected distance visual acuity (BCDVA);Best-corrected near visual acuity (BCNVA);Uncorrected visual acuity;Intraocular pressure (IOP);Pupil diameter;Accommodative amplitude;Tear film stability;

Countries

China

Contacts

Public ContactLina Shang

The First Affiliated Hospital of Zhengzhou University

18638535952@163.com+86 186 3853 5952

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026